These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 31110049)
1. FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice. Rohrbach TD; Asgharpour A; Maczis MA; Montefusco D; Cowart LA; Bedossa P; Sanyal AJ; Spiegel S J Lipid Res; 2019 Jul; 60(7):1311-1322. PubMed ID: 31110049 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis. Mauer AS; Hirsova P; Maiers JL; Shah VH; Malhi H Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G300-G313. PubMed ID: 28039158 [TBL] [Abstract][Full Text] [Related]
3. Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet. Kasbi-Chadli F; Ferchaud-Roucher V; Krempf M; Ouguerram K Eur J Nutr; 2016 Mar; 55(2):589-599. PubMed ID: 25787885 [TBL] [Abstract][Full Text] [Related]
4. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice. Hong Y; Choi SI; Hong E; Kim GH J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753 [TBL] [Abstract][Full Text] [Related]
5. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway. Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744 [TBL] [Abstract][Full Text] [Related]
6. FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells. Berdyshev EV; Gorshkova I; Skobeleva A; Bittman R; Lu X; Dudek SM; Mirzapoiazova T; Garcia JG; Natarajan V J Biol Chem; 2009 Feb; 284(9):5467-77. PubMed ID: 19119142 [TBL] [Abstract][Full Text] [Related]
8. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice. Lee MR; Yang HJ; Park KI; Ma JY Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424 [TBL] [Abstract][Full Text] [Related]
9. Chokeberry attenuates the expression of genes related to de novo lipogenesis in the hepatocytes of mice with nonalcoholic fatty liver disease. Park H; Liu Y; Kim HS; Shin JH Nutr Res; 2016 Jan; 36(1):57-64. PubMed ID: 26773781 [TBL] [Abstract][Full Text] [Related]
10. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity. Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220 [TBL] [Abstract][Full Text] [Related]
11. Artemisia capillaris formula inhibits hepatic steatosis via an miR‑122‑induced decrease in fatty acid synthase expression in vivo and in vitro. Liu L; Zhao J; Li Y; Wan Y; Lin J; Shen A; Xu W; Li H; Zhang Y; Xu J; Peng J; Hong Z Mol Med Rep; 2016 Jun; 13(6):4751-8. PubMed ID: 27081834 [TBL] [Abstract][Full Text] [Related]
15. The sphingosine-1-phosphate analog FTY720 reduces muscle ceramide content and improves glucose tolerance in high fat-fed male mice. Bruce CR; Risis S; Babb JR; Yang C; Lee-Young RS; Henstridge DC; Febbraio MA Endocrinology; 2013 Jan; 154(1):65-76. PubMed ID: 23183172 [TBL] [Abstract][Full Text] [Related]
16. The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats. Lin Z; Wu ZF; Jiang CH; Zhang QW; Ouyang S; Che CT; Zhang J; Yin ZQ Phytomedicine; 2016 Nov; 23(12):1475-1483. PubMed ID: 27765368 [TBL] [Abstract][Full Text] [Related]
17. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease. Kim S; Hong J; Jeon R; Kim HS Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785 [TBL] [Abstract][Full Text] [Related]
18. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice. Luo L; Fang K; Dan X; Gu M Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686 [TBL] [Abstract][Full Text] [Related]
19. Liver sympathetic denervation reverses obesity-induced hepatic steatosis. Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754 [TBL] [Abstract][Full Text] [Related]
20. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice. Hong Y; Sheng L; Zhong J; Tao X; Zhu W; Ma J; Yan J; Zhao A; Zheng X; Wu G; Li B; Han B; Ding K; Zheng N; Jia W; Li H Gut Microbes; 2021; 13(1):1-20. PubMed ID: 34125646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]